The emerging understanding of LAS1L’s significance in tumor progression is underscored by recent findings from the Samant et al. investigation, demonstrating that the knockdown of LAS1L results in reduced proliferation and diminished metastatic potential in triple-negative breast cancer cells [55]. Here, LAS1L is linked to triple-negative breast carcinoma.